More on reports of esophageal cancer with oral bisphosphonate use.
Hofbauer
Lorenz C
LC
Miehlke
Stephan
S
D000230:Adenocarcinoma / Q000139:chemically induced; D000284:Administration, Oral; D001471:Barrett Esophagus / Q000150:complications*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D004938:Esophageal Neoplasms / Q000139:chemically induced*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications; D013997:Time Factors
D050071:Bone Density Conservation Agents; D004164:Diphosphonates